We can't find the internet
Attempting to reconnect
10901.1;4 PFLS-LS
Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events
Résumé
Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events
Textes supplémentaires
Abstract
Development of a clinically superior alternative to today's available coronary artery stents: Qvanteq's Qstent is based on a surface modification of 'bare metal stents' and is expected to accelerate in-growth, which is generally believed to minimize the early and also late adverse cardiac events (i.e. heart attacks) that are associated with today's available 'bare metal stents' as well as 'drug-eluting stents'.
Participants
Georg Noll
Kontaktperson
georg.noll@usz.ch
Universitätsspital Zürich Georg Noll Rämistrasse 100 Klinik für Kardiologie 8091 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2010-07-31
- Date de fin
- 2012-07-18
- Coûts totaux approuvés
- CHF 276135.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- P004 Biochemistry, Metabolism 100.0%